InvestorsHub Logo
Followers 51
Posts 9008
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Friday, 06/02/2023 12:58:55 AM

Friday, June 02, 2023 12:58:55 AM

Post# of 42
Planned MANTRA-2 clinical update at a medical conference in 4Q 2023

PHASE 2- it works very well

Milademetan Shows Early Activity in MDM2-Amplified Advanced Solid Tumors

Notably, activity with the MDM2 inhibitor was observed in patients with heavily pretreated, refractory disease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RAIN News